Abstract:Background The purpose of this study was to employ the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database to mine and analyze adverse events related to iodinated contrast media (ICM), explore the characteristics of adverse events (AEs) including their occurrence and correlation strength between AEs and drugs, and to provide valuable insights for clinical use. Methods The FAERS database was queried, data from Q1 of 2004 to Q2 of 2023 were extracted, and AE reports targeting 5 ICMs as the primary suspects were collected. Data mining and analysis were carried out on relevant reports using the reporting odds ratio (ROR), proportional reporting ratio (PRR), Bayesian confidence propagation neural network (BCPNN), and empirical Bayes geometric mean (EBGM), while the standardized medical dictionary for regulatory activities (MedDRA) queries (SMQ) was used for systematic classification. Results A total of 11,155,106 AE reports were retrieved from FAERS, with 2,412 for ioversol, 2,001 for iohexol, 987 for iodixanol, 1,154 for iopamidol, and 3,835 for iopromide. ICM-induced AE occurrence targeted 21 system organ classes (SOCs). A total of 329 significant disproportionality Preferred terms (PTs) conforming to the 4 algorithms were simultaneously retained. The results revealed that the medium and strong adverse drug reaction (ADR) signals of the 5 ICMs largely focused on "respiratory, thoracic and mediastinal disorders," "general disorders and administration site conditions," "immune system disorders," and "skin and subcutaneous tissue disorders." Ioversol (log 2 ROR = 1.21, P adj = 0.034) and iopromide (log 2 ROR = 1.32, P adj = 0.004) were both correlated with a higher incidence of a significant ADR signal, namely throat irritation, particularly in females. In addition, ioversol and iopromide also suggested that toxic nephropathy (log 2 ROR = −2.47, P adj < 0.001) and hyperhidrosis (log 2 ROR = −1.22, P adj = 0.001) were significant ADR signals, especially in males, respectively. Conclusions While the AE distribution of the 5 ICMs was consistent, there were variations in specific ADR signal characteristics, warranting further consideration and exploration.

Safety Evaluation and Risk Management of Iohexol Injection

Prevention and Treatment of Anaphylactoid Reaction to Ionic and Nonionic Iodinated Contrast Media

[Analysis on the Common Causes for Traditional Chinese Medicinal Injection Induced Adverse Reactions and the Preventive Countermeasures].

Retrospective analysis of non-laboratory-based adverse drug reactions induced by intravenous radiocontrast agents in a Joint Commission International-accredited academic medical center hospital in China

Retrospective Analysis of Acute Adverse Reactions of 4 Iodine Contrast Agents

Retrospective analysis of severe adverse reaction induced by iodine contrast media

Comparative Safety Profiles and Usage Patterns of Iodinated Contrast Media in Medical Imaging

Data Mining and Analysis for Iodinated Contrast Media Adverse Event Signals Based on the Food and Drug Administration Adverse Event Reporting System Database

Hypersensitivity Reactions Induced by Iodinated Contrast Media in Radiological Diagnosis: A Disproportionality Analysis Based on the FAERS Database

Differences in Adverse Reactions Among Iodinated Contrast Media: Analysis of the KAERS Database

Pharmacist-led Iodinated Contrast Media Infusion Risk Assessment Service.

Safety and efficacy of domestic iodixanol injection in interventional neuroradiology:a multicenter clinical trial

Exploring the dark side of diagnostic dyes with a focus on Indocyanine green's adverse reactions

Safety profile of traditional Chinese herbal injection: An analysis of a spontaneous reporting system in China

Adverse Reactions of Iodixanol (270mg I/mL) in Coronary CT Angiography

Analysis of iodixanol-induced delayed hypersensitive reactions in patients undergoing digital subtraction angiography

Renal Tolerability of Iopromide and Iodixanol in 562 Renally Impaired Patients Undergoing Cardiac Catheterisation: the Direct Study

Prevention and Management of Adverse Reactions Induced by Iodinated Contrast Media

Acute Adverse Events After Iodinated Contrast Agent Administration of 359,977 Injections: A Single-Center Retrospective Study

Safety of non-ionic contrast media in CT examinations for out-patients: retrospective multicenter analysis of 473,482 patients

Frequently Asked Questions: Iodinated Contrast Agents